Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
About 10-15% of women experience vulvovaginal candida (thrush) infections and men can also be affected
Start with a low dose to assess the impact and any adverse events
Huang, K
Chakravarthy M, Arguelles-Tello FA, Sun ALA, Elliott M, Acosta L, Rankin JE, et al
/prd-cl/product-medias/8f447f01-b0ce-420c-9118-a623209db925/MK1Y4BURKV/MK1Y4BURKV-1/1753891351201-MK1Y4BURKV-1-2.png)
On May 1, 2025, Eli Lilly announced that it withdrew its FDA application for Zepbound (tirzepatide) for the treatment of HFpEF in patients with obesity, stating that the FDA requires an additional confirmatory trial to support the application
It also supports long-term weight maintenance and overall well-being all key goals for lasting, sustainable health changes
US$ 23.65
US$ 27.72
US$ 23.18
US$ 23.14
US$ 23.78
US$ 29.01
US$ 23.45
US$ 27.78
US$ 25.22
